Fonte: Frontiers in Chemistry. Unidades: EACH, IQSC
Assuntos: NEOPLASIAS, PLANEJAMENTO DE FÁRMACOS, PROTEÍNAS, APOPTOSE
ABNT
CARMO, Aline Lagoeiro do et al. Competition Between Phenothiazines and BH3 Peptide for the Binding Site of the Antiapoptotic BCL-2 Protein. Frontiers in Chemistry, v. 8, p. 235 Apr, 2020Tradução . . Disponível em: https://doi.org/10.3389/fchem.2020.00235. Acesso em: 09 nov. 2024.APA
Carmo, A. L. do, Bettanin, F., Almeida, M. O., Pantaleão, S. Q., Rodrigues, T., Homem-de-Mello, P., & Honório, K. M. (2020). Competition Between Phenothiazines and BH3 Peptide for the Binding Site of the Antiapoptotic BCL-2 Protein. Frontiers in Chemistry, 8, 235 Apr. doi:10.3389/fchem.2020.00235NLM
Carmo AL do, Bettanin F, Almeida MO, Pantaleão SQ, Rodrigues T, Homem-de-Mello P, Honório KM. Competition Between Phenothiazines and BH3 Peptide for the Binding Site of the Antiapoptotic BCL-2 Protein [Internet]. Frontiers in Chemistry. 2020 ; 8 235 Apr.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3389/fchem.2020.00235Vancouver
Carmo AL do, Bettanin F, Almeida MO, Pantaleão SQ, Rodrigues T, Homem-de-Mello P, Honório KM. Competition Between Phenothiazines and BH3 Peptide for the Binding Site of the Antiapoptotic BCL-2 Protein [Internet]. Frontiers in Chemistry. 2020 ; 8 235 Apr.[citado 2024 nov. 09 ] Available from: https://doi.org/10.3389/fchem.2020.00235